Global Industry Size, Trends, Technology, and Analysis by 2035
Date of Publication: 2025-Oct-16
The AI in Oncology Market report is a comprehensive overview of the market, offering key insights into business strategies, current trends, and presenting qualitative and quantitative analysis. This report delves into the major aspects of the global market, providing an in-depth analysis of key drivers, restraints, growth prospects, and risks. The report also includes a detailed evaluation of the competitive landscape and the regional scope of the AI in Oncology industry.
The AI in Oncology Market is being shaped by the entry of new players and the introduction of various products on the market. The report analyzes the key trends influencing the market, and examines factors that impact market growth, including technological advancements and regulatory factors.
The study outlines how different market segments are evolving and growing, offering valuable insights into each element of the industry. The report highlights the growing presence of key players and the strategies they are employing to capture market share. Mergers, acquisitions, product launches, partnerships, and joint ventures are also covered, giving a comprehensive picture of the ongoing developments in the market. This information helps stakeholders understand the shifting dynamics within the AI in Oncology industry.
Origin of Information: https://www.rootsanalysis.com/reports/ai-in-oncology-market.html
The market for AI in Oncology is segmented by Key Report Attributes, Historical Trend, Forecast Period, Market Size 2025, Market Size 2035, CAGR (Till 2035).
Regional analysis is a crucial part of this report, as it highlights the market performance across different regions, including North America, Europe, Asia-Pacific and Rest of the World. The report outlines key details on market production and consumption patterns, import/export activities, and market size in terms of volume and value. It also provides an understanding of supply and demand dynamics in these regions, along with the presence of prominent players.
Key companies profiled in the AI in Oncology Market include Berg (A part of BPGbio), CancerCenter.AI, Concert AI, GE Healthcare, IBM Watson Health, iCAD, JLK Inspection, Median Technologies, Path AI, Roche Diagnostics. These companies are actively involved in the development and expansion of AI in Oncology products, continuously enhancing their market presence through product innovation, partnerships, and strategic collaborations.
The report also presents an analysis of the AI in Oncology industry using various analytical tools, such as SWOT analysis and Porter’s Five Forces. This analysis provides a deeper understanding of market competition, along with insights into the strengths, weaknesses, opportunities, and threats facing market players. With the help of this report, stakeholders can make more informed decisions about where to invest resources and which strategies to adopt to stay ahead of the competition.
The AI in oncology market analysis also features the likely distribution of the current and forecasted opportunity within the AI in oncology domain across various segments, such as type of cancer, type of end user and geographical regions.
We have created three market forecast scenarios, conservative, base and optimistic, to account for future uncertainties in key parameters and enhance the robustness of our model. These scenarios represent different tracks of the industry’s evolution.
Early detection of diseases has demonstrated to significantly improve treatment outcomes and survival rates. The overall success of cancer therapies is heavily reliant on the accurate identification of malignancies and their unique features, allowing healthcare providers to customize treatment plans for each patient effectively.
In May 2025, the Indonesian government along with Perthera and Pathgen Diagnostic Technology partnership along with molecular diagnostics organization aimed at using artificial intelligence to support early diagnosis and treatment for cancer patients and survivors.
In April 2025, University Hospitals Cleveland Medical Center and Qure.ai entered into a strategic partnership focused on deploying the FDA-cleared artificial intelligence qXR-LN for early lung cancer detection via chest X-rays.
In March 2025, Philips announced the expansion of its partnership with Ibex to accelerate the adoption of AI-based digital pathology for efficient cancer diagnosis in response to the global shortage of pathologists and growing number of cancer patients.
In February 2025, Myriad Genetics signed a strategic partnership with PATHOMIQ to add artificial intelligence technology platform to its Oncology Portfolio
In conclusion, this report offers a thorough examination of the AI in Oncology Market, focusing on key trends, regional dynamics, and the competitive landscape. It presents a comprehensive view of the market’s current state and its future potential, offering stakeholders valuable data to make informed decisions and strategically position themselves in the evolving AI in Oncology industry.
About Roots Analysis
Roots Analysis is a global research and consulting powerhouse specializing in Healthcare, Pharmaceutical, Biotech, Semiconductors, Chemicals and ICT industry. With over a decade of experience, they’ve supported more than 750 clients — spanning Fortune 500 companies, innovative startups, academic institutions, VCs, and strategic investors.
Why Use Roots Analysis in era of Artificial Intelligence?
By combining world-class domain expertise, careful data gathering, and dialogue with senior industry experts, Roots Analysis ensures their deliveries are trustworthy, actionable, and aligned with strategic priorities. The value proposition generated on insights generated by Roots Analysis team is unparalleled in the market research industry.
Services Offered:
Roots Analysis offers bespoke consulting services tailored to the unique needs of clients in the life sciences and healthcare sectors.
They specialize in market assessments, tracking industry trends, dynamics, and competitive positioning. These insights help companies fine-tune their product strategies and market-entry plans.
Roots Analysis also delivers expert guidance on partnerships, licensing, and investment opportunities. Their strategic support extends to KOL identification, publication analysis, and regulatory intelligence, making them a valuable partner in business growth and innovation.
With their subscription plans, Roots Analysis provides seamless access to a vast library of market intelligence reports. Subscribers enjoy unlimited downloads in multiple formats.
The service includes on-demand research support—allowing clients to request tailored insights and initiate custom research topics. This ensures that emerging needs are met quickly and effectively.
Each subscription comes with a dedicated account manager and direct access to analysts. Flexible billing options and tiered plans make this service suitable for organizations of all sizes seeking continuous, reliable insights.
Contact Details for Roots Analysis
Chief Executive: Gaurav Chaudhary
Email: [email protected]
Website: https://www.rootsanalysis.com/
